Dr. Uma R. Phatak, MD

Dr. Phatak practices at John Sealy Hospital in Galveston, Texas, part of The University of Texas System.

Dr. Phatak's NPI, 1598014979, was assigned on August 31, 2012. Dr. Phatak graduated from Rutgers New Jersey Medical School in 2009. Dr. Phatak holds Texas license P1208.

Dr. Phatak's primary practice is John Sealy Hospital, at 301 University Boulevard, Galveston, TX 77555 in Galveston County. The practice phone is (409) 772-1011.

Dr. Phatak's primary practice is John Sealy Hospital in Galveston, Texas, part of The University of Texas System. The medical group on file is UTMB Faculty Group Practice.

Dmand AI tracks the electronic health record (EHR) system at each site where Dr. Phatak practices. Vendor and product names are available with a free account.

Colon and rectal surgery is Dr. Phatak's primary specialty in the NPI Registry, under taxonomy code 208C00000X. Dr. Phatak is board certified in colon & rectal surgery by the American Board of Colon and Rectal Surgery. Dmand AI has Dr. Phatak's licenses on file in 2 states: Texas and Massachusetts.

Dmand AI lists colonoscopy, colon removal, gastrointestinal obstruction and hemorrhoids among the conditions Dr. Phatak treats.

CMS data shows 99 Medicare services from Dr. Phatak across 4 procedure codes in 2024, all of them office visits, for 83 Medicare patients. Medicare paid $6,106 for them. Every service was in a facility, such as a hospital, rather than an office.

CMS counts 83 Medicare patients who saw Dr. Phatak in 2024. The largest group is 65 to 74, with 48 patients. 75% of them have high blood pressure, and 66% have high cholesterol. 17% are also on Medicaid. Their average risk score is 1.77, where 1.00 is the Medicare average, so they are sicker than most Medicare patients.

Across all payers, Dmand AI patient panel data puts Dr. Phatak's median patient age at 69, with 61% women.

In 2024, Dr. Phatak wrote 141 Medicare Part D claims for 46 patients. 94% of them were for generic drugs. CMS names the drug for 79 of them, across 4 drugs with 11 or more claims each, at $771 in total drug cost. In 2023, CMS named 77 claims across 4 drugs.

CMS publishes a Merit-based Incentive Payment System (MIPS) score of 79 out of 100 for Dr. Phatak for performance year 2024, reported as part of a group. Dr. Phatak accepts Medicare assignment, so Medicare's approved amount is taken as full payment. CMS counts 13 procedures of colonoscopy by Dr. Phatak, more than 43% of the clinicians it reports for that procedure.

Removal of skin lesions: 1 to 10 procedures (CMS shows small counts as a range)

Upper gastrointestinal (GI) endoscopy for acid reflux: 1 to 10 procedures (CMS shows small counts as a range)

Dmand AI links 22 papers to Dr. Phatak, published from 2013 to 2024. 2013 was the busiest year, with 5. The most frequent topics are Postoperative Complications, Length of Stay and Black or African American. Dr. Phatak has published most often in Ann Surg Oncol. Dr. Phatak's most frequent co-authors are Lillian S. Kao, MD, Curtis J. Wray, MD and George J. Chang, MD.

Dmand AI links Dr. Phatak to 1 clinical trial.

CMS Open Payments shows 30 general payments to Dr. Phatak from 12 drug and device companies from 2016 to 2025. Food and beverage make up the largest share, 79% of the total. Intuitive Surgical, Inc. paid the most, $472.

Dr. Phatak graduated from Rutgers New Jersey Medical School in 2009. Dr. Phatak is a member of ACS, AMA, ASCRS, SSAT, Texas Society of Colon and Rectal Surgeons and Texas Surgical Society.

Dr. Phatak is in network with 22 carriers, including Elevance, Aetna and Blue Cross Blue Shield of Michigan. HMO plans come from the most carriers, 13. Check the plan with the practice before a visit.